We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-20.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.64B
AUM Growth
+$440M
Cap. Flow
+$940M
Cap. Flow %
57.18%
Top 10 Hldgs %
44.47%
Holding
4,515
New
888
Increased
1,264
Reduced
882
Closed
1,360

Sector Composition

Rank Sector Weight
1 Financials 4.61%
2 Industrials 3.56%
3 Consumer Discretionary 3.22%
4 Technology 3.15%
5 Healthcare 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ULBI icon
2501
Ultralife
ULBI
$125M
$3K ﹤0.01%
517
-272
-34% -$1.86K
UMBF icon
2502
UMB Financial
UMBF
$11.5B
$3K ﹤0.01%
+69
New +$4.2K
USA icon
2503
Liberty All-Star Equity Fund
USA
$1.87B
$3K ﹤0.01%
+550
New +$3.4K
VIV icon
2504
Telefônica Brasil
VIV
$18.2B
$3K ﹤0.01%
366
-6,437
-95% -$81.7K
VLY icon
2505
Valley National Bancorp
VLY
$8.29B
$3K ﹤0.01%
378
-20,104
-98% -$197K
VRP icon
2506
Invesco Variable Rate Preferred ETF
VRP
$3.01B
$3K ﹤0.01%
124
-100
-45% -$2.44K
VWO icon
2507
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$3K ﹤0.01%
103
-6,431
-98% -$262K
AIOT
2508
PowerFleet Inc
AIOT
$417M
$3K ﹤0.01%
1,010
-223
-18% -$1.44K
VOXX
2509
DELISTED
VOXX International Corporation Class A
VOXX
$3K ﹤0.01%
1,181
-5,758
-83% -$21.3K
VGR
2510
DELISTED
Vector Group Ltd.
VGR
$3K ﹤0.01%
+523
New +$4.61K
DLA
2511
DELISTED
Delta Apparel Inc.
DLA
$3K ﹤0.01%
321
+79
+33% +$1.69K
SWAV
2512
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$3K ﹤0.01%
+83
New +$3.3K
EXPR
2513
DELISTED
Express, Inc.
EXPR
$3K ﹤0.01%
+102
New +$7.48K
VRTV
2514
DELISTED
VERITIV CORPORATION
VRTV
$3K ﹤0.01%
439
-1,428
-76% -$18.1K
RUBY
2515
DELISTED
Rubius Therapeutics, Inc
RUBY
$3K ﹤0.01%
588
-6,134
-91% -$45.6K
IBMK
2516
DELISTED
iShares iBonds Dec 2022 Term Muni Bond ETF
IBMK
$3K ﹤0.01%
100
PHAS
2517
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$3K ﹤0.01%
824
+451
+121% +$2.06K
RTLR
2518
DELISTED
Rattler Midstream LP Common Units
RTLR
$3K ﹤0.01%
+961
New +$11.8K
SRRA
2519
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$3K ﹤0.01%
+318
New +$4.17K
WVFC
2520
DELISTED
WVS Financial Corp
WVFC
$3K ﹤0.01%
219
-99
-31% -$1.56K
AFI
2521
DELISTED
Armstrong Flooring, Inc.
AFI
$3K ﹤0.01%
2,431
+830
+52% +$2.57K
RESN
2522
DELISTED
Resonant Inc.
RESN
$3K ﹤0.01%
2,341
-483
-17% -$931
FRTA
2523
DELISTED
Forterra, Inc
FRTA
$3K ﹤0.01%
500
-86
-15% -$982
RDS.A
2524
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$3K ﹤0.01%
76
-973
-93% -$45.4K
ECHO
2525
DELISTED
Echo Global Logistics, Inc.
ECHO
$3K ﹤0.01%
187
+165
+750% +$3.21K

Similar funds

Tower Research Capital (TRC)'s Q1 2020 Portfolio in Review

As of Q1 2020, Tower Research Capital (TRC) held 4,515 positions worth $1.64B, up 37% from $1.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tower Research Capital (TRC) deployed $940M of net new capital in Q1 2020, opening 888 new positions and adding to 1,264 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 2.6% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $87.2M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2020 buy was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $101M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $87.2M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2020, selling an estimated $19.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 44% of its $1.64B portfolio in Q1 2020.
  • Tower Research Capital (TRC) opened 888 new positions and closed 1,360 in Q1 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.64B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2020, filed 15 May 2020.